Self-amplifying mRNAs encoding chimeric or mosaic influenza virus hemagglutinin antigens induce broadly protective antibody responses in mice

Authors

• Juan Manuel Carreno Quiroz, Icahn School of Medicine at Mount Sinai, USA
• Anass Abbad, Icahn School of Medicine at Mount Sinai, USA
• Justine S.. McPartlan, Tiba Biotech LLC, USA
• Dominika Bielak, Icahn School of Medicine at Mount Sinai, USA
• Poulami Talukder, Tiba Biotech LLC, USA.
• Keren Greenbaum Schmahmann, Tiba Biotech LLC, USA.
• Eduard Puente-Massaguer, Icahn School of Medicine at Mount Sinai, USA
• Temima Yellin, Icahn School of Medicine at Mount Sinai, USA
• Adolfo García Sastre, Icahn School of Medicine at Mount Sinai, USA
• Sadaf Asla, Icahn School of Medicine at Mount Sinai, USA
• Madhumathi Loganathan, Icahn School of Medicine at Mount Sinai, USA
• Benjamin Francis, Icahn School of Medicine at Mount Sinai, USA
• Leeba Sullivan, Icahn School of Medicine at Mount Sinai, USA
• Miriam Fried, Icahn School of Medicine at Mount Sinai, USA
• Christian W. Mandl, Tiba Biotech LLC, USA
• Jasdave S. Chahal, Tiba Biotech LLC, USA
• Florian Krammer, Icahn School of Medicine at Mount Sinai, USA

Conference Dates

May 19 - 24, 2024

Abstract

Please click Additional Files below to see the full abstract.

Recommended Citation

Juan Manuel Carreno Quiroz, Anass Abbad, Justine S.. McPartlan, Dominika Bielak, Poulami Talukder, Keren Greenbaum Schmahmann, Eduard Puente-Massaguer, Temima Yellin, Adolfo García Sastre, Sadaf Asla, Madhumathi Loganathan, Benjamin Francis, Leeba Sullivan, Miriam Fried, Christian W. Mandl, Jasdave S. Chahal, and Florian Krammer, "Self-amplifying mRNAs encoding chimeric or mosaic influenza virus hemagglutinin antigens induce broadly protective antibody responses in mice" in "Vaccine Technology IX", Linda Lua, The University of Queensland, Australia; Charles Lutsch, Sanofi-Vaccines, France; Francesc Gòdia, Universitat Autònoma de Barcelona (UAB), Spain; Tara Tagmyer, CMC Leader, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/vaccine_ix/51